Merck (MRK) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $0.8.
- Merck's Debt to Equity fell 685.31% to $0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.8, marking a year-over-year decrease of 685.31%. This contributed to the annual value of $0.8 for FY2024, which is 1408.11% down from last year.
- According to the latest figures from Q3 2025, Merck's Debt to Equity is $0.8, which was down 685.31% from $0.72 recorded in Q2 2025.
- Merck's 5-year Debt to Equity high stood at $1.16 for Q1 2021, and its period low was $0.66 during Q1 2023.
- Over the past 5 years, Merck's median Debt to Equity value was $0.8 (recorded in 2025), while the average stood at $0.81.
- Its Debt to Equity has fluctuated over the past 5 years, first crashed by 3283.26% in 2022, then surged by 3978.23% in 2023.
- Merck's Debt to Equity (Quarter) stood at $0.87 in 2021, then fell by 22.99% to $0.67 in 2022, then skyrocketed by 39.78% to $0.93 in 2023, then decreased by 14.08% to $0.8 in 2024, then dropped by 0.4% to $0.8 in 2025.
- Its Debt to Equity was $0.8 in Q3 2025, compared to $0.72 in Q2 2025 and $0.72 in Q1 2025.